To order this 310+ page report, which features 110+ figures
and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html
Key Inclusions
§ A detailed assessment of the overall landscape
of companies with capabilities for continuous manufacturing, along with
information on a number of relevant parameters, such as year of establishment,
company size, purpose of manufacturing (in-house and contract services), scale
of operation (preclinical, clinical and commercial), location of headquarters,
location of manufacturing facilities, type of drug molecule (biologic and small
molecule), type of continuous manufacturing related service(s) offered (process
development, API manufacturing, intermediate manufacturing, drug product
manufacturing, and packaging and fill / finish), type of dosage form (solid and liquid), and
installed capacity and batch size (if available).
§
Elaborate profiles of
some of the key contract manufacturers active in the pharmaceutical and
biopharmaceutical continuous manufacturing market in North America, Europe and
Asia-Pacific. Each profile features an overview of the company, along with
information related to its service portfolio, continuous manufacturing
capabilities and facilities, recent developments and an informed future
outlook.
§
An analysis of the
various partnerships related to continuous manufacturing, which have been
established since 2013, based on several parameters, such as year of an
agreement, the type of partnership (research agreements, facility development /
establishment agreements, technology enhancement agreements, service alliances,
process development agreements, manufacturing agreements and other relevant
agreements), scale of operation (preclinical, clinical and commercial), type of
drug molecule (biologic and small molecule), type of continuous manufacturing
related service (API manufacturing, intermediate manufacturing and end product
manufacturing) and type of dosage form (solid and liquid). It also provides the
regional distribution of the collaborations.
§
An analysis of the
expansions related to continuous manufacturing, which have been established
since 2013, based on several parameters, such as year of an expansion and the
type of expansion (facility / plant expansion, technology installation,
technology enhancement and service expansion), geographical location of the
facility, scale of operation (preclinical, clinical and commercial), type of
drug molecule (biologic and small molecule), type of continuous manufacturing
related service (API manufacturing, intermediate manufacturing and end product
manufacturing) and type of dosage form (solid and liquid).
§
An estimate of the
global, continuous manufacturing capacity, based on the capacities of various
industry stakeholders (as available on their respective company websites). The
study examines the distribution of capacity, based on the type of drug molecule
(biologic and small molecule), company size (small-sized, mid-sized and large),
scale of operation (preclinical, clinical and commercial), location of
headquarters (North America, Europe and Asia-Pacific) and location of manufacturing facilities (North America,
Europe and Asia-Pacific).
§
A study of the
various grants that have been awarded to research institutes engaged in
projects related to continuous manufacturing, between 2014 and 2019,
highlighting multiple parameters, such as year of award, type of grant, grant
amount, focus area, support period, popular recipient organizations, type of
recipient organization, funding institute center, funding mechanism and
prominent program officers.
§
An in-depth analysis
of the various patents that have been filed / granted related to continuous
manufacturing till 2019. It includes information on key parameters, such as
patent type, publication year, geographical location, CPC symbol, emerging
focus areas, type of applicant and leading industry / non-industry players (in
terms of the size of intellectual property portfolio). It also features a
three-dimensional bubble analysis (based on patent citation count, publication
year, extended geographical reach), as well as a patent benchmarking and a
detailed valuation analysis.
§
Initiatives taken by
the leading pharmaceutical companies (in terms of revenues), covering both
partnered as well as in-house projects.
§
A review of the
companies offering modular facilities / modular cleanrooms, with information on
their geographical location (North America, Europe, Asia-Pacific and rest of
the world), year of establishment, company size (small-sized, mid-sized or
large) and type of industries served (pharmaceutical, biotechnology or others).
It also includes information on the recent projects undertaken / executed by
the companies providing modular facilities.
§
A case study of the
companies offering technologies / equipment (continuous blenders and mixers,
continuous granulators, continuous dryers, continuous compressors, continuous
coaters, flow reactors, continuous filtration, distillation and centrifugation
equipment, continuous chromatography, PAT technology and other technologies)
that can potentially be used in a continuous manufacturing process, providing
information on the geographical location of potential stakeholders and the type
of technology / equipment provided.
§
A case study on the
roadmap for the adoption of continuous manufacturing technique, discussing
different strategies that can be followed by the company in order to adopt this
technology or transition from batch manufacturing to continuous manufacturing.
The report also features the likely
distribution of the current and forecasted opportunity across important market
segments, mentioned below:
§ Purpose
of Manufacturing
§
In-House
§
Contract service
§ Scale
of Operation
§
Commercial
§
Preclinical / Clinical
§ Type
of Continuous Manufacturing related Service
§ API
Manufacturing
§ End
Product manufacturing
§ Type
of Drug Molecule
§
Biologic
§
Small Molecule
§ Type
of dosage form
§
Solid
§
Liquid
§ Key
Geographical Regions
§
North America
§
Europe
§
Asia Pacific
§
Transcripts of
interviews held with the following senior level representatives of stakeholder
companies
§
Andrea Adamo, Founder and Chief Executive Officer, Zaiput
Flow technologies
§
Bayan Takizawa, Co-Founder and Chief Business Officer,
CONTINUUS Pharmaceuticals
§
Nick Thomson, Senior Director Chemical Research and
Development, Pfizer
§
Himanshu Gadgil, Director and Chief Scientific Officer,
Enzene Biosciences
§
Eric Fang, Chief Scientific Officer, Snapdragon Chemistry)
§
Ian Houson, Technical Project Manager, Continuous
Manufacturing and Crystallization, University of Strathclyde
To request sample pages, please visit this -
https://www.rootsanalysis.com/reports/308/request-sample.html
Key Questions Answered
§
Who are the key players engaged in continuous manufacturing
of small molecules and biologics?
§ What
is the installed, global capacity for continuous manufacturing?
§ What
are the key growth drivers within this domain?
§ What
are the various paths to evolution within this industry?
§ Who
are the other key stakeholders (modular facility providers and technology /
equipment developers) in this domain?
§
How is the current and future market opportunity likely to
be distributed across key market segments?
You
may also be interested in the following titles:
1.
Pharmaceutical Contract Manufacturing
Market (2nd Edition), 2018-2028
2.
Biopharma Contract Manufacturing Market (3rd Edition), 2019 - 2030
3.
China Pharmaceutical Contract Manufacturing Services Market, 2020-2030
4.
China Biopharmaceutical Contract Manufacturing Market, 2020 - 2030
About Roots Analysis
Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Details
Ben Johnson
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Roots Analysis
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis.com
Medium: https://medium.com/@RootsAnalysis
Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/
Quora: https://rootsanalysisinsights.quora.com/
Comments
Post a Comment